PALM BEACH GARDENS, FL--(Marketwire - Aug 15, 2011) - Aurora Diagnostics Holdings, LLC today announced the retirement of James C. New as CEO and the appointment of Jon L. Hart as CEO and member of the Board of Directors, effective September 1, 2011. Mr. New will remain the Chairman of the Board of Directors and will be a consultant to the company.
Mr. Hart brings to Aurora Diagnostics 26 years of experience in the laboratory industry. Since 2006, he has served as the Senior Vice President and head of Genzyme Genetics, which was sold in 2010 by Genzyme Corporation to Laboratory Corporation of America (LabCorp). From 1998 to 2006, he was a Senior Vice President of Quest Diagnostics with overall responsibility for the western region. Prior to his time at Quest, Mr. Hart was an executive of SmithKline Beecham Clinical Laboratories. Mr. Hart began his professional career in 1979 as a Certified Public Accountant with Arthur Young & Company.
Mr. New is a founder of Aurora Diagnostics and has served as its CEO and Chairman since the company's inception in 2006. He also was instrumental in the development of AmeriPath, Inc., where he was the Chairman and CEO from 1996 to 2003.
Commenting on the hiring of Mr. Hart, Mr. New said, "We are very fortunate to have Jon join Aurora as CEO. Jon brings a wealth of experience in the industry and as a leader. Aurora will benefit from his many talents and his background at Genzyme and Quest and elsewhere. I wish him the best."
Mr. Hart commented, "I am very pleased to join Aurora Diagnostics. I have known Aurora Diagnostics and Jim New for many years. It is a great privilege to take the CEO role and continue the industry-leading position of this excellent company."
Mr. New added, "I'm very proud of what we have built at Aurora since launching the company with two employees in 2006. We have grown Aurora into the largest independent pathology lab in the country and have built an outstanding management team. I would like to thank our leadership team for their many contributions and our exceptional group of industry-leading pathologists who have been instrumental in the growth of the company. I am pleased with Aurora's strong performance this year and know that under Jon's leadership, Aurora will continue to expand its product lines, geographic presence and leadership position in the broader diagnostics industry. I look forward to working with him."
About Aurora Diagnostics Holdings,LLC
Aurora Diagnostics Holdings, LLC of Palm Beach Gardens, Florida is a specialized laboratory company. Founded in 2006, Aurora's mission is to provide outstanding diagnostic services and patient care through its leading clinical staff and customer service professionals. For more information, visit www.auroradx.com.
Contact Information:
FOR INFORMATION, CONTACT:
Gregory Marsh
561 514 7333